Requirement for type 2 NO synthase for IL-12 signaling in innate immunity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 10320373.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Interleukin-12 (IL-12) and type 2 NO synthase (NOS2) are crucial for defense against bacterial and parasitic pathogens, but their relationship in innate immunity is unknown. In the absence of NOS2 activity, IL-12 was unable to prevent spreading of Leishmania parasites, did not stimulate natural killer (NK) cells for cytotoxicity or interferon-gamma (IFN-gamma) release, and failed to activate Tyk2 kinase and to tyrosine phosphorylate Stat4 (the central signal transducer of IL-12) in NK cells. Activation of Tyk2 in NK cells by IFN-alpha/beta also required NOS2. Thus, NOS2-derived NO is a prerequisite for cytokine signaling and function in innate immunity.
Medical subject headings
- Interleukin-12
- Killer Cells, Natural
- Leishmania major
- Leishmaniasis, Cutaneous
- Nitric Oxide Synthase
- Proto-Oncogene Proteins
- Signal Transduction